TACTIC

Targeted Action for Curing Trauma Induced Coagulopathy

Coordinatore	REGION HOVEDSTADEN    more  Organization address address: KONGENS VAENGE 2 city: HILLEROD postcode: 3400 contact info Titolo: Prof. Nome: Pär Cognome: Johansson Email: send email Telefono: +45 23729202
Nazionalità Coordinatore	Denmark [DK]
Totale costo	7˙702˙521 €
EC contributo	5˙880˙010 €
Programma	FP7-HEALTH Specific Programme "Cooperation": Health
Code Call	FP7-HEALTH-2013-INNOVATION-1
Funding Scheme	CP-FP
Anno di inizio	2013
Periodo (anno-mese-giorno)	2013-11-01   -   2018-10-31

 Partecipanti

#	participant	country	role	EC contrib. [€]
1	REGION HOVEDSTADEN  Organization address address: KONGENS VAENGE 2 city: HILLEROD postcode: 3400 contact info Titolo: Prof. Nome: Pär Cognome: Johansson Email: send email Telefono: +45 23729202	DK (HILLEROD)	coordinator	3˙521˙216.50
2	QUEEN MARY UNIVERSITY OF LONDON  Organization address address: 327 MILE END ROAD city: LONDON postcode: E1 4NS contact info Titolo: Prof. Nome: Karim Cognome: Brohi Email: send email Telefono: +44 2035940737 Fax: +44 20 7882 2180	UK (LONDON)	participant	1˙417˙827.90
3	Academisch Medisch Centrum bij de Universiteit van Amsterdam  Organization address address: MEIBERGDREEF 9 city: AMSTERDAM postcode: 1105AZ contact info Titolo: Ms. Nome: Eugenie Cognome: Quartier Email: send email Telefono: +31 205666 188	NL (AMSTERDAM)	participant	251˙778.80
4	Private Universitaet Witten/Herdecke gGmbH  Organization address address: Alfred-Herrhaussen Strasse 50 city: WITTEN postcode: 58448 contact info Titolo: Prof. Nome: Marc Cognome: Maegele Email: send email Telefono: 49221900000000	DE (WITTEN)	participant	200˙366.00
5	THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD  Organization address address: University Offices, Wellington Square city: OXFORD postcode: OX1 2JD contact info Titolo: Dr. Nome: Stephen Cognome: Conway Email: send email Telefono: +44 1865 289800 Fax: +44 1865 289801	UK (OXFORD)	participant	175˙236.00
6	OSLO UNIVERSITETSSYKEHUS HF  Organization address address: FORSKNINGSVEIEN 2B city: OSLO postcode: 373 contact info Titolo: Dr. Nome: Christine Cognome: Gaarder Email: send email Telefono: +47 41318992	NO (OSLO)	participant	172˙182.00
7	TEM INNOVATIONS GMBH  Organization address address: MARTIN KOLLAR STRASSE 13-15 city: MUENCHEN postcode: 81829 contact info Titolo: Mr. Nome: Dieter Cognome: Ober-Jung Email: send email Telefono: +49 89 45 42 95 44 Fax: +49 89 45 42 95 22	DE (MUENCHEN)	participant	87˙092.00
8	HAEMONETICS CORPORATION  Organization address address: WOOD ROAD 400 city: BRAINTREE MA postcode: 2184 contact info Titolo: Dr. Nome: Laurel Cognome: Omert Email: send email Telefono: +1 847 5880453	US (BRAINTREE MA)	participant	54˙311.00

Mappa

 Word cloud

Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.

 Obiettivo del progetto (Objective)

'Trauma remains one of the world’s biggest contributors to the global burden of disease. Predominantly affecting young adults and children, 800,000 European injury related deaths were recorded in 2002. Outcomes for critically injured trauma patients remain poor with severe bleeding, brain injury and tissue damage being associated with high mortality and disability. Nearly half of all trauma fatalities result from haemorrhage, with many patients developing a clotting disorder (coagulaopthy) within minutes of injury or during their clinical care, that worsens bleeding and hampers emergency surgery. Current treatment of bleeding and coagulopathy is based on empirical ”blind” administration of blood products, with large variations in practice between trauma centres.

Important advances in care will only be made by a coordinated European national level approach that pulls discovery research into patients, into clinical guidelines and into national and global policy. “Targeted Action for Curing Trauma Induced Coagulopathy” (TACTIC) is a comprehensive programme of comparative clinical research that will deliver this quantum step in the global health care management of coagulopathic trauma patients, and potentially all patients with acute critical illness.

TACTIC will recruit patients from a network of trauma centres in Amsterdam, Cologne, Copenhagen, London, Oslo and Oxford to compare the effectiveness of different current practices across Europe. It will deliver universal guidelines for how coagulaopathy should be monitored and treated, enabling the individualised treatment of all critically bleeding patients, and and resolve barriers to the subsequent continental implementation of patient-matched targeted transfusion policy, which is expected to reduce trauma haemorrhage-related mortality by approximately ten percent, saving 30.000 lives per year as well as significantly reducing hospital and societal costs.'